Cancer clinical trials in the region Île-de-France

642 currently recruiting clinical trials
Region Île-de-France

Early Access Liver and bile duct cancer
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic HER2 1 2 3 or more Chemotherapy
Systemic Treatment-Naive
1 recruiting site
Jazz Pharmaceuticals
Early Access Bladder / Urinary Tract / Urethral cancer
Invasive bladder cancer Urothelial carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
1 recruiting site
Merck Sharp & Dohme LLC
Early Access Bladder / Urinary Tract / Urethral cancer
Invasive bladder cancer Urothelial carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
1 recruiting site
Astellas Pharma Développement mondial, Inc.
Early Access Kidney cancer Pancreas cancer
Clear cell carcinoma Neuroendocrine tumor Localized Von Hippel-Lindau syndrome (VHL)
1 recruiting site
Merck Sharp & Dohme LLC
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 2 3 or more
Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR 1 Targeted therapy
Systemic Treatment-Naive
1 recruiting site
Janssen
Phase 3 Sarcoma and GIST #NCT07218926 #2025-522229-37-00
GIST Locally Advanced Metastatic KIT PDGFRA 1 Targeted therapy
Systemic Treatment-Naive
8 recruiting sites
GlaxoSmithKline
Phase 3 Endometrial cancer #NCT07044336 #2024-518777-34-00
Locally Advanced Metastatic 1 2 Immunotherapy Chemotherapy
Systemic Treatment-Naive
13 recruiting sites
AstraZeneca
Phase 3 Lymphoma CLL & Richter's syndrome #NCT05254743 #2023-507699-38-00
B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Lymphocytic lymphoma None > 60 ml/min 50-60 ml/min 30-50 ml/min Other mutation None Systemic Treatment-Naive
10 recruiting sites
Loxo Oncology
Phase 3 Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN) #NCT04256317
Myelodysplastic syndromes (MDS) MDS de novo Secondary MDS Chronic myelomonocytic leukemia (CMML) Other MDS Systemic Treatment-Naive High Very high High Very high Intermediate-2 High
Chemotherapy
3 recruiting sites
Taiho Oncology